Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
EVERSANA unveils global price and market access solution NAVLIN by EVERSANA
2022-03-17 19:10
First eye drops registered on the Australian Register of Therapeutic Goods (ARTG) to slow the progression of short-sightedness now available for children aged from 4 to 14 years old[1]
2022-03-17 17:00
KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn
2022-03-17 15:30
Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma
2022-03-17 08:00
Henlius 2021 Annual Results: New Record in Performance, Evolving to Biopharma
2022-03-16 23:46
Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology
2022-03-16 21:09
Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform
2022-03-16 20:38
Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies
2022-03-16 19:00
Adagene Announces FDA Clearance to Proceed with Phase 1b/2 Trial of Anti-CTLA-4 ADG126 SAFEbody® in Combination Therapy With Anti-PD-1 Antibody Pembrolizumab
2022-03-16 19:00
Mentice receives order of ten (10) VIST simulator systems in China for a value exceeding 500,000 USD
2022-03-16 15:43
Beyond a platform, Ping An Good Doctor aiming to be a pillar of China's healthcare sector
2022-03-16 15:17
SNIPR BIOME expands its Executive Management team and opens offices in the US and UK
2022-03-16 14:28
Pasture Announces First Halal-Certified Surgical N95 Masks for Healthcare and Public Use
2022-03-16 13:00
Gene Solutions Makes Earlier Detection of Cancer A Possibility of the Future
2022-03-16 09:36
Brii Bio Announces that National Health Commission of China Adds Amubarvimab/Romlusevimab Combination to its COVID-19 Diagnosis and Treatment Guidelines (9th Pilot Edition)
2022-03-16 09:00
Evercare Group launches Evercare Foundation to help bridge the gap in inequality in healthcare
2022-03-15 20:22
Business Update on ASC10, an Oral Double Prodrug against COVID-19
2022-03-15 19:55
Animal health company Emollivet raises capital and strengthens team
2022-03-15 15:48
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress
2022-03-15 12:47
Everest Medicines to Announce Full-Year 2021 Financial Results on March 29, 2022
2022-03-15 09:00
1
166
167
168
169
170
492